Ισραήλ - Εβραϊκά - Ministry of Health

"ניאופרם (ישראל) 1996 בע""מ" - כלל האוכלוסיה - מוצרי ד'ר שול לכף הרגל

Ισραήλ - Εβραϊκά - Ministry of Health

fischer pharmaceuticals ltd - alcohol 70 %v/v - gel - ethanol - antiseptic gel for hands (hand sanitizer ).

Ισραήλ - Εβραϊκά - Ministry of Health

teva medical ltd - alcohol 70 %w/v; chlorhexidine gluconate 0.5 %w/v - solution - external - chlorhexidine - antiseptic hand rub.

Ισραήλ - Εβραϊκά - Ministry of Health

גפן מדיקל בע"מ - אחות - מגבוני אלכוהול לחיטוי העור לפני הזרקות או לפני לקיחת דגימות דם

Ισραήλ - Εβραϊκά - Ministry of Health

אלול שירותי עזר רפואיים בע"מ - אחר - מנשף לבדיקת אלכוהול בנשימה

Ισραήλ - Εβραϊκά - Ministry of Health

cts chemical industries ltd - paroxetine as hydrochloride - טבליה - paroxetine as hydrochloride 30 mg - paroxetine - paroxetine - treatment of symptoms of depressive illness of all types including depression accompanied by anxiety. treatment of symptoms and prevention of relapse of obsessive compulsive disorder (ocd). treatment of symptoms and prevention of relapse of panic disorder with or without agoraphobia.treatment of symptoms of social phobia. post traumatic stress disorder. generalised anxiety disorders.

Ισραήλ - Εβραϊκά - Ministry of Health

dexcel ltd, israel - venlafaxine as hydrochloride - קפליות - venlafaxine as hydrochloride 75 mg - venlafaxine - venlafaxine - for the treatment of depression.maintenance of recurrent depression, generalized anxiety disorder (gad) - short term and long-term, social anxiety disorder (sad).

Ισραήλ - Εβραϊκά - Ministry of Health

dexcel ltd, israel - venlafaxine as hydrochloride - קפליות - venlafaxine as hydrochloride 150 mg - venlafaxine - venlafaxine - for the treatment of depression.maintenance of recurrent depression, generalized anxiety disorder (gad) - short term and long-term, social anxiety disorder (sad).

Ισραήλ - Εβραϊκά - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Ισραήλ - Εβραϊκά - Ministry of Health

allergan israel ltd - polyvinyl alcohol 1.4 % - ophthalmic solution - ethanol - ocular lubricant.